Last reviewed · How we verify

Coniel — Competitive Intelligence Brief

Coniel (BENIDIPINE) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: benidipine. Area: Hematology.

marketed benidipine Voltage-dependent T-type calcium channel subunit alpha-1H, Voltage-gated L-type calcium channel Hematology Small molecule Live · refreshed every 30 min

Target snapshot

Coniel (BENIDIPINE).

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Coniel TARGET BENIDIPINE marketed benidipine Voltage-dependent T-type calcium channel subunit alpha-1H, Voltage-gated L-type calcium channel
Cinalong CILNIDIPINE phase 3 cilnidipine Voltage-dependent N-type calcium channel subunit alpha-1B, Voltage-dependent T-type calcium channel subunit alpha-1H, Voltage-gated L-type calcium channel

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (benidipine class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Coniel — Competitive Intelligence Brief. https://druglandscape.com/ci/benidipine. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: